Olema Pharmaceuticals Q3 EPS $(0.73) Misses $(0.63) Estimate
Benzinga Newsdesk 7 hours ago
NewsEarningsEarnings Misses
Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.63) by 17.74 percent. This is a 48.98 percent decrease over losses of $(0.49) per
Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.63) by 17.74 percent. This is a 48.98 percent decrease over losses of $(0.49) per share from the same period last year.